Abstract：Objective To analyze the factors influencing treatment quality of non-small cell lung cancer (NSCLC) through calculating the comprehensive score of index of NSCLC treatment quality, and to provide a basis for improving the treatment quality of NSCLC. Methods We collected the case information about hospital patients with NSCLC. The comprehensive score oftreatment quality in the patients was calculated based on the evaluation indicator system of NSCLC. A Beta regression model was established with the comprehensive score as the dependent variable and the influencing factors as the independent variable. Univariate and multivariate analyses were conducted to identify the factors influencing treatment quality. Results A total of 767 patients with NSCLC were collected, and the comprehensive score of treatment quality was (0.768±0.118) points. Results of multivariate analysis showed that there were statistically significant differences in gender, work, medical insurance status, complications, histological grade, lymph node dissection and cancer stage (P<0.05). Among them, female patients (OR=0.761, 95%CI: 0.678-0.854), patients with work (OR=0.783, 95%CI:0.647-0.947), patients with complications (OR=0.703,95%CI:0.618-0.800), and patients with advanced cancer (OR=0.458, 95%CI: 0.345-0.609) had lower comprehensive scores. Patients with new rural cooperative medical insurance (OR=1.563, 95%CI: 1.278-1.912), middle and low histological differentiation (OR=1.292, 95%CI:1.020-1.638) and lymph node dissection (OR=1.288, 95%CI:1.007-1.665) had higher treatment quality. Conclusion The analysis of factors affecting treatment quality of NSCLC suggests that reducing occupational stress, improving the operation rate of lymph node dissection and promoting the indicator compliance rate of patients withcomplications and advanced cancer are of great significance to the improvement of quality of NSCLC treatment.
[1] Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer[J]. Nature, 2018, 553(7689):446-454. [2] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018[J]. CA Cancer J Clin, 2018, 68(1):7-30. [3] 杜冬明,刘晓红,杨延平,等.2014—2018年浙江省丽水市肺癌发病和死亡趋势分析[J].实用预防医学,2021,28(2):212-215. [4] Blumenthal D. Part 1:Quality of care: What is it?[J].N Engl J Med, 1996,335(12):891-894. [5] 栗景坤,李习,刘美娜.基于评价指标的非小细胞肺癌治疗质量影响因素分析[J].中国医院统计,2018,25(6):405-409. [6] Wang X, Su S, Li S, et al. Development of quality indicators for non-small cell lung cancer care: a first step toward assessing and improving quality of cancer care in China[J]. BMC Cancer, 2017, 17(1):603. [7] Ferrari S, Cri Ba Ri-Neto F. Beta regression for modelling rates and proportions[J]. J Appl Stat, 2004, 31(7):799-815. [8] Zeileis A, Cribari-Neto F, Grün B, et al. Beta regression in R[J]. J Stat Softw, 2010, 34(2):1-24. [9] 王超,刘美娜.疾病治疗质量综合评价方法研究进展[J].中国医院统计,2020,27(6):568-571,576. [10] Donabedian A. Evaluating quality of medical care [J]. Milbank Q, 1966, 83(4):691-729. [11] 包晓蔷,刘美娜,王玉鹏.基于评价指标的乳腺癌治疗质量影响因素分析[J].中国医院统计,2020,27(5):397-402. [12] Battafarano RJ,Piccirillo JF,Meyers BF,et al. Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer[J]. J Thorac Cardiovasc Surg, 2002, 123(2):280-287. [13] 肖瑞, 李华, 席庆,等. 年龄及术前合并症对口腔癌患者术后并发症的影响[J]. 解放军医学杂志, 2015, 40(1):56-59. [14] 刘继文,王治明,王绵珍,等.职业紧张对免疫功能的影响[J].中国工业医学杂志,2002,15(2):100-101. [15] 王爽英,李金鑫.职业压力对职业健康的影响机理及应对措施[J].轻工科技,2017,33(1):110-112. [16] 高晓燕,苏比努尔·西日艾力,刘继文.新疆医学院校专职教师职业紧张对其睡眠质量的影响分析[J].实用预防医学,2021,28(4):461-465. [17] 李岚, 许斌, 武杰,等. 原发灶手术对Ⅳ期非小细胞肺癌患者生存的影响[J]. 中华肿瘤杂志, 2021, 43(3): 335-344. [18] 李丹, 包郁. 循证护理对中晚期肺癌化疗患者心理状态及生活质量的影响[J]. 中国肿瘤临床与康复, 2018, 25(2): 245-248. [19] 张少毅,梁轶,徐聃,等.我国新农合背景下家庭灾难性医疗费支出研究进展[J].行政事业资产与财务,2020,15(15):58-60. [20] Li X,Zhou Q,Wang X,et al. The effect of low insurance reimbursement on quality of care for non-small cell lung cancer in China: a comprehensive study covering diagnosis, treatment, and outcomes[J]. BMC Cancer, 2018,18(1):683.
2022, Vol. 29 
